Aripiprazole-associated tic in a schizophrenia patient
Xieli Guo,1,2,* Dali Lu,3,* Yugang Jiang1 1Department of Neurosurgery, Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China; 2Department of Neurosurgery, Jinjiang Hospital of Quanzhou Medical College, Jinjiang, Fujian, People&...
Enregistré dans:
Auteurs principaux: | Guo X, Lu D, Jiang Y |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5ba670c575544c00a9a0322b1f8c55b0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Role of aripiprazole in treatment-resistant schizophrenia
par: Mossaheb N, et autres
Publié: (2012) -
Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
par: Wang SM, et autres
Publié: (2014) -
Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis
par: De Hert M, et autres
Publié: (2015) -
Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
par: Kishi T, et autres
Publié: (2015) -
An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
par: Giorgio L Colombo, et autres
Publié: (2008)